GO:0006572 L-tyrosine catabolic process: Tyrosine Degradation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006572 (L-tyrosine catabolic process) describes the chemical reactions and pathways that break down L-tyrosine, one of the aromatic amino acids.
• L-tyrosine catabolism is a central node in aromatic amino acid metabolism and connects to energy production, neurotransmitter precursor pools, and melanin synthesis.
• The pathway is relevant to hepatic failure because tyrosine utilization and clearance are impaired in liver disease.
• Melanocytes actively transport and metabolize L-tyrosine, making the pathway important in pigmentation biology and melanoma research.
• Biotechnological interest in L-tyrosine catabolism and its reverse (biosynthesis) spans metabolic engineering, fermentation, and biocatalysis.
• Tracing L-tyrosine uptake and turnover is clinically relevant in neurooncology, where radiolabeled tyrosine analogs are used for tumor imaging.
Description
L-tyrosine is an aromatic amino acid that serves as a precursor for proteins, catecholamines, thyroid hormones, and melanin. The Gene Ontology term GO:0006572, L-tyrosine catabolic process, defines the set of biochemical reactions that result in the breakdown of L-tyrosine. This process is essential for maintaining amino acid homeostasis and for recycling carbon and nitrogen skeletons into central metabolism. Understanding L-tyrosine catabolism is important because defects or alterations in this pathway can influence liver function, pigmentation, and tumor metabolism. In plants, aromatic amino acid biosynthesis and catabolism are tightly linked to the shikimate pathway, which provides precursors for a wide range of secondary metabolites. In microorganisms, L-tyrosine catabolism supports carbon source utilization and contributes to the production of specialized compounds. In mammals, the liver is a major site of tyrosine degradation, and impaired tyrosine catabolism is observed in hepatic failure. Melanocytes also depend on L-tyrosine transport and metabolism for melanin production, linking this pathway to pigmentation disorders and melanoma. Recent advances in biocatalysis have expanded the industrial relevance of L-tyrosine and its derivatives, further motivating research into its catabolic routes. Metabolic engineering efforts in Escherichia coli have optimized L-tyrosine production, and understanding catabolism is critical to avoid product degradation. In neurooncology, radiolabeled L-tyrosine analogs such as O-(2-[18F]-fluoroethyl)-L-tyrosine (FET) are used to image amino acid transport and metabolism in brain tumors, indirectly reflecting tyrosine handling. Thus, GO:0006572 is a focal point for researchers in biochemistry, hepatology, dermatology, oncology, and biotechnology.
L-tyrosine catabolic process At A Glance
| GO ID | GO:0006572 |
|---|---|
| GO term | L-tyrosine catabolic process |
| Ontology | biological_process |
| Synonym | tyrosine breakdown, tyrosine catabolism, tyrosine degradation |
| Major function | Breakdown of L-tyrosine into metabolic intermediates |
| Related pathway | Aromatic amino acid metabolism; shikimate pathway in plants |
| Clinical relevance | Hepatic failure, pigmentation, neurooncology |
| Biotechnological relevance | Metabolic engineering and biocatalysis |
What Is GO:0006572?
GO:0006572, L-tyrosine catabolic process, is defined as the chemical reactions and pathways resulting in the breakdown of L-tyrosine. It encompasses the enzymatic steps that convert L-tyrosine into downstream metabolites, ultimately contributing to energy production and nitrogen disposal. This term is a biological process in the Gene Ontology and is synonymous with tyrosine breakdown, tyrosine catabolism, and tyrosine degradation.
Why Is L-tyrosine catabolic process Important in Cell Biology?
L-tyrosine catabolic process (GO:0006572) is important because it governs the fate of an amino acid that is central to protein synthesis, neurotransmitter production, and pigmentation. In clinical settings, impaired tyrosine catabolism is associated with hepatic failure, where the liver's capacity to utilize tyrosine-containing compounds is reduced. In cancer research, tyrosine metabolism influences tumor growth and is exploited in imaging modalities such as FET PET. In biotechnology, controlling tyrosine catabolism is essential for efficient production of L-tyrosine and its derivatives. Therefore, studying this pathway provides insights into human disease, microbial physiology, and industrial biocatalysis.
• Maintains amino acid homeostasis by removing excess L-tyrosine.
• Supports hepatic function; tyrosine utilization is impaired in liver failure.
• Provides precursors for melanin synthesis in melanocytes.
• Influences tumor metabolism and is targeted by radiolabeled tyrosine analogs in neurooncology.
• Plays a role in microbial carbon and nitrogen metabolism.
• Is a key consideration in metabolic engineering for L-tyrosine production.
• Links to the shikimate pathway in plants, affecting secondary metabolite production.
• Serves as a model for studying enzyme kinetics and pathway regulation.
• Has implications for pigmentation disorders and melanoma research.
• Contributes to the development of biocatalytic derivatization processes.
What Happens During L-tyrosine catabolic process?
Uptake and Transport of L-tyrosine
In simple terms: Cells first bring L-tyrosine inside before breaking it down.
L-tyrosine is transported into cells by specific amino acid transporters. In B16/F10 malignant melanocytes, L-tyrosine transport has been characterized as a saturable process, indicating carrier-mediated uptake. This step is essential for subsequent catabolic reactions, as the substrate must be available intracellularly. In hepatic failure, the utilization of tyrosine-containing dipeptides and N-acetyl-tyrosine is altered, reflecting changes in transport and catabolism.
Initial Transamination and Deamination
In simple terms: The amino group is removed from L-tyrosine to prepare it for further breakdown.
The catabolism of L-tyrosine typically begins with transamination, where the amino group is transferred to an acceptor, forming p-hydroxyphenylpyruvate. This reaction is catalyzed by tyrosine aminotransferase. Although specific enzymes are not detailed in the provided citations, the general principle of amino acid catabolism involves deamination. In plants, aromatic amino acid biosynthesis and catabolism are interconnected, with transamination playing a role in nitrogen recycling.
Fumarate and Acetoacetate Production
In simple terms: The carbon skeleton of L-tyrosine is converted into intermediates that enter energy metabolism.
The breakdown of L-tyrosine yields fumarate and acetoacetate, which can enter the citric acid cycle and ketone body metabolism, respectively. This is a classic feature of aromatic amino acid catabolism. In metabolic engineering, understanding these downstream steps is crucial for optimizing L-tyrosine production, as degradation can reduce yields. The shikimate pathway in plants provides aromatic amino acids, and their catabolism feeds into central metabolism.
Role of Cofactors and Enzymes
In simple terms: Vitamins and metal ions help the enzymes that break down L-tyrosine work properly.
L-tyrosine catabolism requires cofactors such as pyridoxal phosphate for transamination and ascorbate for hydroxylation steps. These cofactors are essential for enzyme activity. In biocatalytic derivatization, cofactor regeneration is often a key consideration for efficient conversion of L-tyrosine. The precise cofactor requirements can vary among organisms, but the general dependence on pyridoxal phosphate is conserved.
Tissue-Specific Catabolism
In simple terms: Different organs break down L-tyrosine in different ways.
The liver is a major site of L-tyrosine catabolism, and in hepatic failure, the utilization of tyrosine-containing compounds is impaired. Melanocytes also catabolize L-tyrosine for melanin synthesis, with transport being a regulated step. In neurooncology, brain tumors show altered tyrosine metabolism, which can be visualized using FET PET. Thus, catabolism is tissue-specific and context-dependent.
Key Genes Involved in GO:0006572 L-tyrosine catabolic process
The following genes and proteins are involved in L-tyrosine catabolic process and related pathways, based on the provided literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TAT | Tyrosine aminotransferase; catalyzes transamination of L-tyrosine | Liver-specific catabolism; hepatic failure models |
| HPD | 4-hydroxyphenylpyruvate dioxygenase; converts p-hydroxyphenylpyruvate | Involved in tyrosine degradation; potential target in metabolic engineering |
| HGD | Homogentisate 1,2-dioxygenase; aromatic ring cleavage | Alkaptonuria research; catabolic pathway |
| GSTZ1 | Maleylacetoacetate isomerase; detoxification and catabolism | Liver metabolism; hepatic failure |
| FAH | Fumarylacetoacetate hydrolase; final step of tyrosine catabolism | Hereditary tyrosinemia type I; liver disease models |
| SLC7A11 | Cystine/glutamate antiporter; influences amino acid transport | Melanoma and oxidative stress |
| SLC3A2 | Amino acid transporter subunit; facilitates L-tyrosine uptake | Melanocyte transport studies |
| TYR | Tyrosinase; uses L-tyrosine for melanin synthesis | Pigmentation and melanoma |
| DCT | Dopachrome tautomerase; melanin pathway | Melanocyte biology |
| PAH | Phenylalanine hydroxylase; converts phenylalanine to tyrosine | Phenylketonuria; tyrosine homeostasis |
| AroA | EPSP synthase; shikimate pathway | Plant aromatic amino acid biosynthesis |
| AroB | Dehydroquinate synthase; shikimate pathway | Microbial tyrosine biosynthesis |
| AroC | Chorismate synthase; shikimate pathway | Plant and microbial metabolism |
| AroD | Dehydroquinate dehydratase; shikimate pathway | Biocatalysis and metabolic engineering |
| AroE | Shikimate dehydrogenase; shikimate pathway | L-tyrosine production |
| AroK | Shikimate kinase; shikimate pathway | Fermentation optimization |
| AroL | Shikimate kinase II; shikimate pathway | Metabolic engineering |
| PheA | Chorismate mutase/prephenate dehydratase; phenylalanine biosynthesis | Aromatic amino acid regulation |
How Is L-tyrosine catabolic process Regulated?
L-tyrosine catabolic process is regulated at multiple levels. In plants, the shikimate pathway and aromatic amino acid biosynthesis are subject to feedback inhibition and transcriptional control. In mammals, hepatic tyrosine catabolism is influenced by hormonal signals and nutritional status, as evidenced by altered utilization in hepatic failure. In melanocytes, L-tyrosine transport is a regulated step, affecting the availability of substrate for both catabolism and melanin synthesis. In biotechnological settings, metabolic engineering strategies often involve modulating pathway flux to prevent degradation of L-tyrosine during production. Additionally, the use of tyrosine-containing dipeptides in hepatic failure suggests that substrate form can influence catabolic rates.
L-tyrosine catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FAH | Hereditary tyrosinemia type I | Fah knockout mouse; liver organoids |
| TAT | Tyrosinemia type II | Tat knockout cell lines; hepatic failure models |
| HPD | Tyrosinemia type III | Hpd knockout cells; metabolic engineering |
| TYR | Oculocutaneous albinism; melanoma | B16/F10 melanocytes; Tyr knockout mice |
| SLC7A11 | Cancer metabolism; oxidative stress | Melanoma cell lines; transporter assays |
Hepatic Failure and Tyrosine Metabolism
In hepatic failure, the liver's ability to utilize tyrosine-containing dipeptides and N-acetyl-tyrosine is compromised, indicating impaired L-tyrosine catabolism. This can lead to altered amino acid balance and requires careful nutritional management.
Melanoma and Pigmentation Disorders
Melanocytes transport L-tyrosine for melanin synthesis, and this transport is characterized in B16/F10 malignant melanocytes. Dysregulation of tyrosine metabolism can affect pigmentation and melanoma progression.
Neurooncology and Tumor Imaging
O-(2-[18F]-fluoroethyl)-L-tyrosine (FET) is used in neurooncology to image amino acid transport and metabolism in brain tumors. This reflects the importance of tyrosine handling in cancer biology.
Inherited Metabolic Disorders
Although specific enzyme deficiencies are not detailed in the provided citations, defects in L-tyrosine catabolism are known to cause diseases such as tyrosinemia. The general pathway is critical for liver function.
From L-tyrosine catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TAT affect tyrosine catabolism? | TAT knockout hepatocytes |
| Can a point mutation in FAH mimic tyrosinemia? | FAH point-mutation knock-in mice |
| How does overexpression of TYR affect melanin synthesis? | TYR overexpression in melanocytes |
| What is the role of SLC7A11 in tyrosine transport? | SLC7A11 knockout melanoma cells |
| Can tagged HPD be used to track localization? | HPD tagged knock-in cell lines |
| Does metabolic engineering of AroE increase tyrosine production? | E. coli overexpression strains |
How to Study the L-tyrosine catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isotopic labeling | Flux through catabolic pathway | Metabolic engineering |
| Enzyme activity assay | Catalytic rate of catabolic enzymes | Biochemical characterization |
| Transport assay | Uptake kinetics of L-tyrosine | Melanocyte biology |
| FET PET | Tyrosine transport and metabolism in vivo | Neurooncology imaging |
| Fermentation monitoring | L-tyrosine production and degradation | Biotechnology |
| Biocatalytic derivatization | Conversion of L-tyrosine to derivatives | Industrial biocatalysis |
| Hepatic function tests | Utilization of tyrosine compounds | Liver disease research |
| Chromogenicity assay | Streptomyces pigment formation | Microbial secondary metabolism |
Metabolic Flux Analysis
Metabolic flux analysis using isotopic labeling can trace the catabolism of L-tyrosine through downstream metabolites. This approach is valuable in metabolic engineering to quantify pathway activity.
Enzyme Activity Assays
Enzyme activity assays for transaminases and dioxygenases measure the catalytic steps of L-tyrosine catabolism. These assays are used to characterize enzyme kinetics and inhibition.
Transport Studies
Transport studies using radiolabeled L-tyrosine or fluorescent analogs characterize uptake kinetics in cells such as melanocytes. Such studies are essential to understand substrate availability for catabolism.
Imaging with Radiolabeled Tracers
FET PET imaging allows non-invasive assessment of tyrosine transport and metabolism in tumors. This method is used in neurooncology to visualize tumor metabolism.
How CRISPR Can Be Used to Study GO:0006572 L-tyrosine catabolic process
Knockout
CRISPR knockout of genes such as TAT, HPD, or FAH can disrupt L-tyrosine catabolism, leading to accumulation of upstream metabolites. These models are useful to study metabolic disorders and liver function.
Point Mutation
Introducing point mutations in catabolic enzymes can mimic inherited metabolic diseases, such as tyrosinemia. This allows precise dissection of enzyme function and substrate specificity.
Knock-in
Knock-in of tagged versions of enzymes like HPD or FAH enables tracking of protein localization and interactions. This is valuable for understanding pathway compartmentalization.
Overexpression
Overexpression of catabolic genes or transport proteins can increase flux through L-tyrosine catabolism. This approach is used in metabolic engineering to optimize production or degradation.
How EDITGENE Supports L-tyrosine catabolic process Research
Researchers studying L-tyrosine catabolic process-related genes often need to determine whether a candidate gene is causally involved in the pathway, and CRISPR-based models provide a precise way to test this. EDITGENE offers a suite of services to support such investigations.
Contact EDITGENE today to design your custom CRISPR model for L-tyrosine catabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TAT Knockout HEK293 Cell Line | EDJ-KQ2159 | Human | 6898 | Details Get a Quote |
| IL4I1 Knockout HEK293 Cell Line | EDJ-KQ3808 | Human | 259307 | Details Get a Quote |
| GSTZ1 Knockout HEK293 Cell Line | EDJ-KQ4816 | Human | 2954 | Details Get a Quote |
| HGD Knockout HEK293 Cell Line | EDJ-KQ4862 | Human | 3081 | Details Get a Quote |
| HPD Knockout HEK293 Cell Line | EDJ-KQ4931 | Human | 3242 | Details Get a Quote |
| GSTZ1 Knockout HeLa Cell Line | EDJ-KQ26373 | Human | 2954 | Details Get a Quote |
| HGD Knockout A-549 Cell Line | EDJ-KQ26430 | Human | 3081 | Details Get a Quote |
| HPD Knockout A-549 Cell Line | EDJ-KQ26559 | Human | 3242 | Details Get a Quote |
| GSTZ1 Knockout A-549 Cell Line | EDJ-KQ27592 | Human | 2954 | Details Get a Quote |
| GSTZ1 Knockout HCT 116 Cell Line | EDJ-KQ27593 | Human | 2954 | Details Get a Quote |
| HPD Knockout HeLa Cell Line | EDJ-KQ27771 | Human | 3242 | Details Get a Quote |
| FAH Knockout A-549 Cell Line | EDJ-KQ42832 | Human | 2184 | Details Get a Quote |
| FAH Knockout HCT 116 Cell Line | EDJ-KQ42833 | Human | 2184 | Details Get a Quote |
| FAH Knockout HeLa Cell Line | EDJ-KQ42834 | Human | 2184 | Details Get a Quote |
| FAH Knockout Hep-G2 Cell Line | EDJ-KZ233 | Human | 2184 | Details Get a Quote |
Displaying Records 1 To 15 Of 27 Records
Frequently Asked Questions About L-tyrosine catabolic process
What is GO:0006572?
GO:0006572 is the Gene Ontology term for L-tyrosine catabolic process, describing the breakdown of L-tyrosine.
What genes are involved in L-tyrosine catabolic process?
Genes such as TAT, HPD, HGD, GSTZ1, and FAH are involved in the catabolic pathway.
Why is L-tyrosine catabolism important in liver disease?
In hepatic failure, the liver's ability to utilize tyrosine-containing compounds is impaired, affecting amino acid balance.
How is L-tyrosine catabolism studied?
It is studied using enzyme assays, isotopic labeling, transport assays, and imaging techniques like FET PET.
What is the role of L-tyrosine in melanocytes?
Melanocytes transport L-tyrosine for melanin synthesis, and this transport is a regulated process.
Can CRISPR be used to study L-tyrosine catabolism?
Yes, CRISPR knockout, point mutation, and knock-in models can be used to dissect gene function in this pathway.
What diseases are linked to L-tyrosine catabolism?
Diseases include tyrosinemia, hepatic failure, and pigmentation disorders such as albinism.
How is L-tyrosine used in neurooncology?
Radiolabeled L-tyrosine analogs like FET are used to image amino acid transport in brain tumors.
What is the shikimate pathway?
The shikimate pathway is a metabolic route for aromatic amino acid biosynthesis in plants and microbes, linked to L-tyrosine.
What are the synonyms for L-tyrosine catabolic process?
Synonyms include tyrosine breakdown, tyrosine catabolism, and tyrosine degradation.
Conclusion
GO:0006572, L-tyrosine catabolic process, is a fundamental biological pathway with wide-ranging implications in human health, disease, and biotechnology. Understanding its regulation and genetic components can lead to advances in treating metabolic disorders, cancer, and liver disease. Researchers can leverage CRISPR-based models and metabolic engineering tools to further dissect this pathway.
References
- 1. Maeda H et al.. 2012. The shikimate pathway and aromatic amino Acid biosynthesis in plants.. Annu Rev Plant Biol 63:73-105 PMID: 22554242
- 2. Druml W et al.. 1995. Utilization of tyrosine-containing dipeptides and N-acetyl-tyrosine in hepatic failure.. Hepatology 21(4):923-8 PMID: 7705801
- 3. Tan X et al.. 2020. Recent advances in biocatalytic derivatization of L-tyrosine.. Appl Microbiol Biotechnol 104(23):9907-9920 PMID: 33067683
- 4. Jara JR et al.. 1990. Transport of L-tyrosine by B16/F10 malignant melanocytes: characterization of the process.. Pigment Cell Res 3(6):290-6 PMID: 1983230
- 5. Chen Z et al.. 2025. Systems metabolic engineering and process optimization for efficient l-tyrosine production from high-purity glucose syrup in Escherichia coli.. Bioresour Technol 425:132306 PMID: 40015532
- 6. Arai T et al.. 1972. Chromogenicity of Streptomyces.. Appl Microbiol 23(2):402-6 PMID: 4622831
- 7. Li G et al.. 2020. Enhancing the efficiency of L-tyrosine by repeated batch fermentation.. Bioengineered 11(1):852-861 PMID: 32749196
- 8. Stegmayr C et al.. 2019. O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental Results.. Curr Radiopharm 12(3):201-210 PMID: 30636621
